Human TSPAN7 Antibody, R&D Systems™

Mouse Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB9179SP	R&D Systems MAB9179SP	25 μg
MAB9179100	R&D Systems MAB9179100	100 μg

Description

TSPAN7/TM4SF2 Monoclonal specifically detects TSPAN7/TM4SF2 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.

Specifications

• Antigen: TSPAN7/TM4SF2
• Dilution: Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
• Gene Alias: A15, A15CCG-B7, CCG-B7, CD231, CD231 antigen, Cell surface glycoprotein A15, DXS1692E, Membrane component chromosome X surface marker 1, mental retardation, X-linked 58, MRX58, MXS1, MXS1T-cell acute lymphoblastic leukemia associated antigen 1, TALLA-1, T-cell acute lymphoblastic leukemia-associated antigen 1, tetraspanin 7, tetraspanin-7, TM4SF2, TM4SF2b, TM4SF2tetraspanin protein, transmembrane 4 superfamily 2b, Transmembrane 4 superfamily member 2X chromosome, surface marker 1, transmembrane protein A15, Tspan-7
• Immunogen: HEK293 human embryonic kidney cell line transfected with human TSPAN7 Accession # P41732
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
• Test Specificity: Stains human TSPAN7 transfectants but not irrelevant transfectants in flow cytometry.

• Clone: 482618
• Applications: Flow Cytometry, CyTOF
• Conjugate: Unconjugated
• Host Species: Mouse
• Target Species: Human
• Gene Accession No.: P41732
• Gene ID (Entrez): 7102
• Isotype: IgG2a
• Purification Method: Protein A or G purified from hybridoma culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.